News
Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
There could be a new use for semaglutide, the main ingredient of weight loss and diabetes drugs Wegovy and Ozempic. Dr. Jon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results